Status:
UNKNOWN
Clonidine Versus Granisetron for Shivering Prevension
Lead Sponsor:
Zagazig University
Conditions:
Post Spinal Anesthesia Shivering
Eligibility:
FEMALE
21-40 years
Phase:
PHASE2
Brief Summary
Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption
Detailed Description
Shivering is one of the most important periperative complications seen in clinical practice. Several mechanisms have been postulated for its pathogenesis. Anesthetic-induced inhibition of thermoregula...
Eligibility Criteria
Inclusion
- Patient acceptance.,Aged between 21-40 years old, BMI: 18- 30 kg/m2, ASA: I and II., Scheduled for elective cesarean section under spinal anesthesia.
- \-
Exclusion
- History of hypersensitivity to drugs used in this study,Patients with history of chronic pain and taking analgesics, Patients with sepsis and Significant cardiac, liver or renal diseases, Uncooperative patients or with psychiatric disorders that prevent surgery under spinal anesthesia, Atrio-ventricular block in any degree, cardiac arrhythmias, valvular heart disease, kidney or liver diseases, neuromuscular disorders and diabetes mellitus
- \-
Key Trial Info
Start Date :
March 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT06031090
Start Date
March 5 2023
End Date
October 30 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heba M Fathi
Zagazig, Egypt, 44519